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Summary
Background: Actomyosin contractility is the major cellular
force driving changes in cell and tissue shape. A principal
regulator of contractility is the small GTPase RhoA. External
mechanical forces have been shown to impact RhoA activity
and cellular contractility. However, the mechanotransduction
pathway from external forces to actomyosin contractility is
poorly understood.
Results: Here, we show that actomyosin contractility in the
C. elegans spermatheca is under control of RHO-1/RhoA,
which, in turn, is regulated by the F-BAR and RhoGAP protein
SPV-1. In the relaxed spermatheca, SPV-1 localizes through
its F-BAR domain to the apical membrane, where it inhibits
RHO-1/RhoA activity through its RhoGAP domain. Oocyte
entry forces the spermatheca cells to stretch, and subse-
quently SPV-1 detaches from the membrane, permitting
RHO-1 activity to increase. The increase in RHO-1 activity
facilitates spermatheca contraction and expulsion of the newly
fertilized embryo into the uterus, leading to relaxation of the
spermatheca, SPV-1 membrane localization, and initiation of
a new cycle.
Conclusions: Our results demonstrate how transient mem-
brane localization of a novel F-BAR domain, likely via specific
binding to curved membranes, coupled to a RhoGAP domain,
can provide feedback between a mechanical signal (mem-
brane stretching) and actomyosin contractility. We anticipate
this to be a widely utilized feedback mechanism used to
balance actomyosin forces in the face of externally applied
forces, as well as intrinsic processes involving cell deforma-
tion, from single-cell migration to tissue morphogenesis.
Introduction
Actomyosin-mediated contractility is a universal mechanism
for producing force in both muscle and nonmuscle cells. Coar-
rangements of actin and myosin work in concert to mediate
important cellular processes, including cytokinesis, cell migra-
tion, and morphogenesis. Importantly, several lines of evi-
dence suggest that external forces can modulate internal
contractility. For example, smooth muscle cells that form the
airway and endothelium have been documented to regulate
their contractile behavior in response to cyclical stress result-
ing from breathing and blood flow, respectively [1–4]. At the
molecular level, mechanical forces from external perturba-
tions, such as shear, compressive, or tensile stress, have
been shown to modulate contractility through the regulation
of RhoA activity [2, 5].*Correspondence: biezbr@nus.edu.sgThe small GTPase RhoA is a well-established regulator of
actomyosin contractility functioning primarily through two
downstream effectors: the diaphanous-related formin (Dia1)
and the Rho-associated serine/threonine kinase (ROCK)
[6, 7]. Activated Dia1 is involved in the nucleation and elonga-
tion of actin filaments [6], whereas ROCK promotes myosin
activation through phosphorylation of myosin light-chain
(MLC) and myosin light-chain phosphatase (MLCP) [8, 9].
Although the downstream effectors of RhoA are well charac-
terized, the transduction pathways through which mechanical
stimuli lead to RhoA activation are far less understood. RhoA is
activated by guanine nucleotide exchange factors (RhoGEFs),
which facilitate the exchange of GDP for GTP [10], and is
switched off by hydrolysis of GTP to GDP, a process greatly
enhanced by GTPase activating proteins (RhoGAPs) [11].
Guanine nucleotide dissociation inhibitors (GDIs) function to
bind and maintain the inactive pool of RhoA in the cytosol
[12], whereas active RhoA localizes to the plasma membrane
[13–15]. Thus, the spatiotemporal regulation of RhoA depends
on the spatiotemporal localization of RhoGAPs and/or
RhoGEFs. Indeed, tensional forces applied to integrins induce
activation of RhoA through the recruitment of the RhoGEFs
GEF-H1 and LARG to focal adhesions [16]. However, it is
unclear by what mechanism RhoGEFs and RhoGAPs can
change their localization in response to external forces.
Current understanding of how external forces lead to RhoA-
mediated contractile events is primarily derived from in vitro
cell-based studies [5]. Here, we propose a system in which
mechanical regulation of RhoA activity in an epithelial tube
can be investigated in vivo. During C. elegans ovulation, an
oocyte is released into the spermatheca, an accordion-like
myoepithelial pouch composed of 24 cells, which houses the
sperm [17, 18]. Fertilization takes place in the spermatheca
immediately upon oocyte entry, and orchestrated constric-
tion of the spermatheca subsequently propels the fertilized
embryo into the uterus. The spermathecal cells are lined with
circumferential actin bundles [19] and spermathecal constric-
tion is dependent on the balance between the activity of Rho-
kinase and myosin light-chain phosphatase [20]. Biochemical
signaling involving inositol 1,4,5-triphosphate (IP3)-mediated
calcium release also represents an important component in
the cyclic regulation of spermatheca contractility [21]. This is
evident from studies conducted in mutants defective in the
calcium-signaling pathway [22–24]. Although components
involved in spermathecal constriction have been identified,
the mechanism regulating the timing of constriction initiation
remains elusive.
Here, we identified a RhoGAP protein, spermatheca physi-
ology variant 1 (SPV-1), which utilizes an F-BAR domain to
transiently bind the apical membrane, presumably by
sensing changes in membrane curvature. In the absence of
an oocyte, the spermatheca resembles a deflated balloon
with heavily convoluted membrane folds lining the collapsed
lumen (www.wormimage.org). During ovulation, stretching
of the spermatheca cells by the incoming oocyte [19, 21]
serves as an intrinsic mechanism to modulate cell membrane
curvature. Spatiotemporal control of SPV-1 localization en-
sures that RHO-1/RhoA activity rises at the correct time after
Figure 1. SPV-1 Regulates Spermatheca Contractility
(A) Wild-type and spv-1(ok1498)mutant embryos. Arrows and arrowheads indicate elongated and round embryos, respectively. See also Figure S1. Scale
bar, 50 mm.
(B) Schematic of C. elegans hermaphrodite reproductive system. Inset shows the region imaged in (C).
(legend continued on next page)
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143ovulation. Hence, we propose that SPV-1 serves as a mecha-
notransducer linking changes in membrane curvature to the
regulation of RHO-1 activity and downstream actomyosin
contraction.
Results
SPV-1 Is a Regulator of Spermatheca Contractility
In an RNAi screen of C. elegans RhoGAPs, we found SPV-1 to
be essential for embryonic viability and for the generation of
embryos with normal shape. We confirmed these phenotypes
using a 577 bp frameshift deletion allele of spv-1, ok1498,
which lacks part of the RhoGAP domain. The stereotypical
geometry of wild-typeC. elegans embryos is a prolate ellipsoid
of revolution with an axial ratio of 1.69 (mean) 6 0.014 (SEM)
(n = 50) (Figure 1A; Figure S1A available online). In contrast,
spv-1(ok1498) or spv-1(RNAi) knockdown resulted in embryos
of irregular geometries and sizes with axial ratios ranging from
1.00 to 2.83 (n R 50), and 41% of spv-1(ok1498) and 50% of
spv-1(RNAi) embryos failed to hatch (n > 300) (Figure 1A; Fig-
ure S1A). Interestingly, we observed a bias of developmental
arrest in embryos with axial ratios below 1.69 (Figure S1A).
Previous studies reported that misregulation of spermatheca
contractility can give rise to embryos of aberrant geometries
[19, 25]. We therefore analyzed the transit of embryos through
the spermatheca, using live differential interference contrast
(DIC) microscopy, to compare the spermatheca function be-
tween wild-type and spv-1(ok1498) hermaphrodites. Figure 1B
illustrates the C. elegans gonad, and the enlarged region indi-
cates the field of imaging. Figure 1C shows representative
images from such movies. Ovulation, the passage of the
most proximal oocyte from the gonad into the spermatheca,
took 1 min in both wild-type and spv-1(ok1498) worms (Fig-
ure 1C). Complete ovulation is defined by the closure of the
distal spermatheca valve and is referred to as time 0. Oocyte
entry into the spermatheca is known to be closely followed
by fertilization [18]. In the wild-type hermaphrodite, the newly
fertilized embryo resided in the spermatheca for 240 s before
the spermatheca constricted and propelled the embryo into
the uterus through the opening of the spermatheca-uterine
(sp-ut) valve (Figure 1C; Movie S1). In contrast, the sperma-
theca of the spv-1(ok1498) mutant began to display a con-
stricted morphology after only 60 s and forced a premature
exit of the embryo into the uterus (Figure 1C; Movie S2).
Despite the precocious and excessive contraction of the
spermatheca in spv-1 mutant worms, the average time for
embryos to completely exit the spermatheca in spv-
1(ok1498) (115.8 6 13.84, n = 24) is not significantly different
from wild-type (92.35 6 12.84, n = 23) (Figure S1B). This is
because, whereas some embryos transit through the mutant
spermatheca more rapidly than wild-type, others become
trapped by the overconstricted spermatheca for extended
periods of time, as shown in Figure S1C, and occasionally
they are severed by the spermatheca.(C) Representative ovulation and embryo transit events in wild-type and spv-1
is referred to as time 0. Valve-to-valve time is defined by the interval betw
Oo, oocyte; Sp, spermatheca. Scale bar, 20 mm.
(D) Quantification of constriction magnitude and valve-to-valve time in wild-typ
the measurement of the ratio between distal (W1) and proximal (W2) spermath
dots) with mean 6 SEM. nR 23 for each worm strain analyzed. Statistical com
isons test.
(E) SPV-1 expression pattern. SPV-1::GFP under the regulation of its endogeno
autofluorescence of the gut granules. Asterisk denotes the embryos. Scale ba
(F) Quantification of embryonic lethality in spv-1 loss-of-function and after resTo quantify the magnitude of spermathecal constriction, we
measured the width at its distal (W1) and proximal quarters
(W2) prior to opening of the sp-ut valve and calculated their
ratio. A nonconstricted spermatheca will have a W1/W2
ratio close to one, whereas constriction of the distal sperma-
theca will result in ratios lower than one. Quantification of
the constriction magnitude in spv-1(ok1498) worms (n = 28)
showed a 31% increase in constriction (p < 0.0001) compared
to wild-type spermatheca (n = 25) (Figure 1D). We also quanti-
fied the valve-to-valve time, defined as the time between com-
plete closure of the distal spermatheca valve and opening
of the sp-ut valve. Closure of the distal valve signifies the
completion of ovulation, and the opening of the sp-ut valve
accompanies the beginning of spermathecal contraction.
The mean valve-to-valve time in spv-1(ok1498) mutants
(94.5 6 10.3 s, n = 28) was significantly shorter than in wild-
type animals (247.2 6 11.61 s, n = 25) (p < 0.0001), confirming
that spermatheca constriction not only is stronger in the
mutant, but also has an earlier onset (Figure 1D). Precocious
constriction of the spermatheca in spv-1(ok1498) mutants is
also evident by following the change in constrictionmagnitude
over the course of a single-embryo transit event in both wild-
type and mutant worms (Figure S1D) (n = 7). In the wild-type
worms W1/W2 gradually increased and plateaued before
slightly decreasing prior to sp-ut valve opening. In contrast,
the width of the spermatheca in the spv-1(ok1498) worms
decreased as soon as the oocyte completed ovulation and
continued to decrease until embryo exit (n = 7) (Figure S1D).
Given the apparent function of SPV-1 in the spermatheca,
we sought to determine its expression pattern. To this end,
we constructed a translational fusion of SPV-1 with GFP driven
by its endogenous promoter. We observed SPV-1::GFP to
be expressed exclusively in the spermathecal cells (Figure 1E,
arrowheads). Importantly, the full-length translational con-
struct successfully rescued all the mutant phenotypes: sper-
mathecal constriction magnitude and valve-to-valve time
were restored to wild-type levels (n = 23) (Figure 1D); embry-
onic lethality was eliminated (n = 370) (Figure 1F), and embryo
morphology was restored to wild-type dimensions (Fig-
ure S1E). It is worth noting that 48% of the embryo transit
events did not result in complete embryo exit, probably due
to overexpression of SPV-1::GFP. The fact that we did not
observe expression of SPV-1::GFP in embryos (Figure 1E,
asterisk) suggested that the embryonic lethality associated
with loss of spv-1 function is solely due to the aberrant
spermatheca activity and is a consequence of abnormal
embryo shapes. To confirm this, we drove spv-1 expression
using the spermatheca-specific promoter of sth-1 [26] in
spv-1(ok1498) worms. As expected, spermathecal expres-
sion alone was sufficient to rescue embryonic lethality along
with the embryo shape defect (Figure 1F; Figure S1E). Further-
more, we crossed spv-1(ok1498) hermaphrodites with either
wild-type or spv-1(ok1498) males and scored for embryo-
nic lethality. A slight reduction in embryonic lethality was(ok1498) animals. Complete closure of the distal valve (complete ovulation)
een distal valve closure and opening of the spermatheca-uterine valve.
e, spv-1(ok1498), and SPV-1::GFP transgenic line. Constriction magnitude is
eca widths. Data are represented as individual embryo transit events (gray
parisons were performed using one-way ANOVA-Tukey’s multiple compar-
us promoter is expressed in the spermatheca (arrowheads). Arrows indicate
r, 100 mm.
toration of SPV-1 function. N indicates the number of embryos analyzed.
Figure 2. SPV-1 Functions Upstream of the RhoA-ROCK Pathway
(A) Effect of RHO-1 knockdown on embryo transit through the spermatheca. Representative images taken from movies of control (L4440) and rho-1(RNAi)
treated animals. The spermatheca (highlighted in orange) in the rho-1(RNAi) animal did not contract during the 30 min imaging period, and two embryos
(highlighted in pink) can be seen trapped within it. Oo, oocyte; Sp, spermatheca. Scale bar, 20 mm.
(B) Live imaging of active RHO-1 biosensor (AHPH::GFP) in wild-type and spv-1(ok1498) spermatheca. Arrows and arrowheads indicate an accumulation of
AHPH::GFP. Scale bar, 20 mm.
(C) In vitro RhoGAP activity assay measuring GAP activity toward recombinant mammalian RhoA shows GAP activity of the RhoGAP domain of SPV-1.
(legend continued on next page)
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145observed in cross-progeny regardless of the genotype of the
males, indicating that the partial paternal rescue (possibly
due to an unknown relaxing effect of male sperm on the
spermatheca) was not due to the presence of a zygotic copy
of wild-type spv-1 (Figure S1F). Thus, SPV-1 is a newly discov-
ered regulator of spermatheca contractility, and in this capac-
ity it has a profound impact on embryonic viability.
SPV-1 Regulates Contractility through the
RHO-1/RhoA-LET-502/ROCK Pathway
Because SPV-1 has a putative RhoGAP domain, we postu-
lated that SPV-1 functions to regulate RHO-1 activity in the
spermatheca. However, the contribution of RHO-1 to sperma-
theca contractility has not yet been reported. To test the
consequence of reducing RHO-1 levels on spermatheca
contractility, we performed partial rho-1 knockdown using
feeding RNAi. Knockdown of rho-1 for 36 hr resulted in com-
plete loss of spermathecal contractility and embryos being
trapped in the spermatheca (n = 14) (Figure 2A). Importantly,
a milder 24 hr rho-1 RNAi treatment in the mutant background
rescued the spv-1(ok1498) hypercontractile phenotype and
restored normal embryo transit (n = 4) (Figure S2A), suggest-
ing that the early and hypercontractile spermathecal pheno-
types we observed in spv-1 loss of function were due
to excessive RHO-1 activity. To directly test this possibility,
we utilized a recently established RHO-1 activity reporter
comprising of the Rho-binding domain of C. elegans anillin
ANI-1 (AHPH) [27] fused to GFP to monitor RHO-1 activity in
the spermatheca during embryo transit. In wild-type worms,
we observed a gradual increase in the intensity of the active
RHO-1 sensor at the distal end of the spermatheca during
the time between distal valve closure to the opening of
sp-ut valve, and the intensity peaked during embryo exit (Fig-
ure 2B, arrows). In contrast, the spermatheca of spv-1(ok1498)
worms displayed an immediate accumulation of the active
RHO-1 sensor upon distal valve closure (Figure 2B, arrow-
heads). We confirmed the efficacy of the RHO-1 sensor by
knocking down rho-1 in the spv-1(ok1498) worms carrying
the RHO-1-biosensor. As shown in Figure S2B, under these
conditions a premature accumulation of the biosensor at the
distal end of the spermatheca was not observed. These
results indicate that SPV-1 normally functions to suppress
the level of active RHO-1 in the spermatheca during the initial
stages of embryo transit.
To demonstrate that the RhoGAP domain of SPV-1 directly
regulates Rho activity, we performed an in vitro RhoGAP activ-
ity assay using purified recombinant proteins. As expected,
the RhoGAP domain of SPV-1 was able to enhance the hydro-
lysis of GTP toGDPbymammalian RhoA (Figure 2C). To estab-
lish that the RhoGAP domain is essential for SPV-1 function
in vivo, we introduced into spv-1(ok1498) worms full-length
SPV-1 engineered with a nonfunctional RhoGAP domain,
SPV-1(R635K)::GFP. Transgenic mutants carrying the dead-
GAP construct were indistinguishable from spv-1(ok1498)
mutants alone in terms of spermatheca constriction magni-
tude and valve-to-valve time (Figure 2D). Similar results
were obtained with a complete truncation of the RhoGAP
domain (Figure 2D). These results confirm the importance of
the RhoGAP catalytic domain of SPV-1 in maintaining low(D) Quantification of the constriction magnitude and valve-to-valve time for tra
let-502(sb106). Quantification for spv-1(ok1498) is duplicated from Figure 1F.
mean 6 SEM. nR 18 for each worm strain analyzed. Statistical comparisons
(E) Circumferential actin bundles in wild-type and spv-1(ok1498) mutant spermlevels of RHO-1 activity in the spermatheca in the first few
minutes of embryo transit.
Based on work in other systems, it is well established that
RhoA can regulate actomyosin contractility via two indepen-
dent pathways: (1) activation of formins, which leads to actin
filament polymerization; (2) activation of Rho-kinase, which
leads to myosin activation through phosphorylation of MLC
andMLCP [6–9]. Todeterminewhether elevatedRHO-1activity
in the spermatheca results in changes to the circumferential
actin bundles, we visualized actin filaments using a YFP::
ACT-5 reporter. As shown in Figure 2E, there was no discern-
able difference between the actin structures of mutant and
wild-type spermathecae at the resolution of the light micro-
scope. Next, we tested the involvement of let-502/Rho-Kinase
in mediating the effects of RHO-1 in the spermatheca. To this
end, we performed a genetic cross between spv-1(ok1498)
and let-502(sb106), a Rho-kinase hypomorph [28]. Importantly,
the overconstriction phenotype was alleviated in the double
mutant, suggesting that SPV-1 functions upstream of Rho-ki-
nase (Figure 2D). Taken together, our results suggest that the
RhoGAP domain of SPV-1 plays an essential role in regulating
spermatheca contractility via the RhoA-ROCK pathway.
SPV-1 Localization at theApicalMembrane of Spermatheca
Cells Is Transient
The subcellular localization pattern of SPV-1 during embryo
transit was determined by live imaging of SPV-1::GFP using
confocal microscopy (Figure 3A). During the initial phase of
embryo transit (0 s) we observed SPV-1 to be enriched at the
apical membrane. Importantly, the membrane signal progres-
sively diminished and disappeared (180 s) prior to the opening
of the sp-ut valve (360 s) (Figure 3A). To understand the tempo-
ral relationship between the loss of apical SPV-1, the rise
in RHO-1, and the initiation of spermatheca constriction, we
quantified the enrichment of SPV-1::GFP at the membrane,
from the completion of ovulation until the initiation of embryo
exit, and plotted these data alongside the quantification of
RHO-1 levels using the same temporal framework (Figure 3B).
This analysis clearly showed that levels of membrane-bound
SPV-1 began to diminish immediately after ovulation, and no
membrane enrichment was detected halfway through the
embryo retention period (membrane/cytoplasm ratio of 1).
Concomitant with the loss of SPV-1 from the membrane,
RHO-1 levels gradually increased, and at the midpoint of the
embryo retention period, RHO-1 levels began to climb more
rapidly, reaching a maximum when embryo exit was complete
(Figure 3B).
A Novel F-BAR Domain in SPV-1 Mediates
Membrane Binding
To elucidate the molecular mechanism responsible for the
transient binding of SPV-1 to the membrane, we performed
a bioinformatics analysis on the amino acid sequence of
SPV-1. A conserved domain search [29] revealed anN-terminal
Fes/Cip4 homology (FCH) and phorbolesters/diacylglycerol
binding (C1) domains in addition to the RhoGAP domain (Fig-
ure 4A, top panel). Coiled-coil motif analysis [30] predicted the
presence of a coiled-coil (CC) region closely following the FCH
domain (Figure 4A, top panel). Taken together, an FCH domainnsgenic worms depleted of RhoGAP activity and Rho-kinase hypomorphs,
Data are represented as individual embryo transit events (gray dots) with
were performed using one-way ANOVA-Tukey’s multiple comparisons test.
atheca visualized with YFP::ACT-5. Scale bar, 20 mm
Figure 3. SPV-1 Transiently Localizes to the Plasma Membrane
(A) Representative images of SPV-1::GFP subcellular localization during embryo transit. Graphs show the intensity profile of lines drawn perpendicular to the
spermatheca cells. Black and white arrowheads highlight the differences in intensity between the cell edge and cytoplasm. Scale bars: whole spermatheca,
20 mm; inset, 5 mm.
(B) Quantification of SPV-1::GFP membrane accumulation and AHPH::GFP total intensity during embryo transit. The valve-to-valve time (time interval
between completion of ovulation and initiation of embryo exit) on the x axis is normalized to a scale of 0–1 to enable the line plots to be superimposed
on the same graph. Light-colored lines represent individual embryo transit events; bold lines are mean values quantified from the light-colored lines.
See Supplemental Experimental Procedures for details on quantifications.
146followed by a coiled-coil region indicates the presence of
a putative F-BAR domain [31–33]. Figure 4A (bottom panel)
shows the predicted structure of SPV-1 modeled using
the default intensive setting of Phyre2 [34]. Using Domain
Enhanced Lookup Time Accelerated Basic Local Alignment
Search Tool (DELTA-BLAST) [35], we identified orthologs
of SPV-1, which included the putative F-BAR domain, in all
metazoan genomes searched from sponges to mammals
(Figure 4B). Interestingly, we also identified an ortholog in
the premetazoan Monosiga brevicollis (XP_001748029.1), but
none in Fungi or Amoeba. There appears to be a single SPV-
1 ortholog in eachmetazoan species up to chordates, whereas
vertebrates have three orthologs. The three human orthologs
are the GEM interacting protein (GMIP), Rho GTPase-acti-
vating protein 29 (ARHGAP29, also known as PARG1), and
minor histocompatibility protein HA-1 (HMHA1). GMIP and
ARHGAP29 have not been characterized to have an F-BAR
domain, whereas HMHA1 was recently reported to harbor
a BAR domain [36]. Phylogenetic analysis of previously
described F-BAR domains and SPV-1 orthologs indicates
that the F-BAR domain of SPV-1 and its orthologs form a
distinct class of F-BAR domains (Figure 4C).
We used the 2.4 A˚ crystal structure of the N-terminal domain
of human GMIP (PDB ID: 3QWE) as a template to predict thestructure of the F-BAR domain of SPV-1 using I-TASSER
[37]. Figure 4D shows two views of the predicted structure of
a putative dimer formed by two SPV-1 F-BAR domains. The
side view (top panel) shows that the F-BAR dimer is predicted
to form a shallow concave curvature, as expected for F-BAR
domains. The bottom panel, which shows the membrane-
interacting surface of the F-BAR dimer, highlights the high
number of positive amino acid residues along this surface,
which are expected to interact with the negatively charged
membrane.
To experimentally test the role of the F-BAR domain in local-
izing SPV-1 transiently to the plasma membrane, we created
an SPV-1 construct lacking its F-BAR domain (spv-1p::spv-
1DF-BAR::GFP) and examined its localization pattern in the
mutant background. As expected, membrane localization of
SPV-1was abolished in the absence of the F-BARdomain (Fig-
ure S3A). However, the expression of the DF-BAR construct
was dramatically reduced compared to the full-length protein.
To circumvent this problem, we drove SPV-1DF-BAR::GFP
under the sth-1 promoter, which gave higher expression.
Even with higher expression, SPV-1DF-BAR::GFP remained
strictly cytoplasmic (Figure 4E). Interestingly, loss of mem-
brane localization did not affect the RhoGAP activity of the
truncated protein but rather prolonged the valve-to-valve
Figure 4. F-BAR Domain of SPV-1 Mediates Membrane Binding
(A) Top panel, protein domains of SPV-1. Bottom panel, predicted protein structure of SPV-1. Purple, F-BAR domain; green, C1 domain; red, RhoGAP
domain.
(B) Multiple sequence alignment of the F-BAR domain of a selection of SPV-1 orthologs from sponges to mammals. See Table S1 for the NCBI reference
sequences. Blue, A, I, L, M, F, W, V, and C; red, R and K; green. N, Q, S, and T; pink, C; magenta, E and D; orange, G; cyan, H and Y; yellow, P. Refer to
http://www.jalview.org/help/html/colourSchemes/clustal.html for the full color scheme.
(C) Unrooted phylogenic tree depicting human F-BAR domains and selected C. elegans orthologs. The F-BAR domain of SPV-1 and its human orthologs
(HMHA1, GMIP, and ARHGAP29) form a distinct group (gray cloud). ce, C. elegans; hs, H. sapiens. See Table S2 for a list of NCBI reference sequences.
(D) Predicted structure of the F-BAR dimer. Top panel shows the side view of a ribbon representation. Bottom panel shows the membrane-interacting sur-
face with positive amino acid residues highlighted in blue and negative residues in red.
(E) Representative images of SPV-1DF-BAR::GFP driven by the sth-1 promoter showing its subcellular localization during embryo transit.
(legend continued on next page)
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148time as compared to wild-type worms (Figure 4F). We hypoth-
esize that the F-BAR domain, when not bound to the mem-
brane, inhibits the RhoGAP activity either through direct
interaction, or by steric hindrance. An inhibitory role for an
F-BAR domain on RhoGAP and other domains, such as SH3,
has been previously reported for other F-BAR proteins [38,
39]. Recently, de Kreuk et al. reported that the RhoGAP activity
of HMHA1, which we identified as one of the human orthologs
of SPV-1, is autoinhibited by its BAR domain because only
mutants lacking the BAR domain showed GAP activity toward
RhoGTPases [36]. This supports the idea that deletion of the
F-BAR domain may have created an SPV-1 with constitutive
RhoGAP activity, which could explain its ability to rescue the
mutant. However, our attempts to detect an interaction be-
tween the N (F-BAR-containing) and C (RhoGAP-containing)
terminus of SPV-1 in a pull-down assay, using bacterially syn-
thesized protein fragments, were unsuccessful.
Taken together, bioinformatics, structural prediction, and
localization experiments indicate that SPV-1 harbors a novel
highly conserved F-BAR domain that mediates its binding to
the plasma membrane.
Transient Membrane Localization of SPV-1 Is Required
for Embryo Transit through the Spermatheca
The evidence thus far suggested that spermatheca stretching
by an incoming oocyte, sensed by the F-BAR domain, leads to
SPV-1 detachment from the plasma membrane and subse-
quent increase in RHO-1 and spermatheca contraction. As a
test of this model, we investigated the consequence of consti-
tutively localizing SPV-1 to the membrane. For this purpose,
we substituted the F-BAR domain with a pleckstrin homology
(PH) domain from rat phospholipase C gamma 1 (PLC1s1) and
introduced the chimeric SPV-1::GFP construct into the mutant
worm. The transgenic worms displayed permanent SPV-
1::GFP localization on the apical membrane of spermatheca
cells (Figure 5A). Notably, instead of a single embryo per sper-
matheca transiting within approximately 6 min in wild-type
worms, each spermatheca we observed in the strain express-
ing constitutive membrane-bound SPV-1 was occupied by
multiple embryos and none of the embryos exited the sperma-
theca during the 30 min imaging period (n = 10) (Figures 5A
and 5B; Movie S3). These results indicate that prolonged
attachment of SPV-1 to the membrane hinders the initiation
of spermertheca contractility, most likely due to reduced
RHO-1 activity at the plasma membrane. Thus, detachment
of SPV-1 from themembrane, facilitated by the F-BAR domain,
functions as a cue to initiate spermathecal contractility and
embryo exit.
Discussion
Taken together, our findings support a model in which SPV-1
regulates cyclical contraction of the spermatheca through
transient localization to the apical membrane mediated by
its F-BAR domain (Figure 5C). We presume SPV-1 localization
to be membrane curvature dependent. When localized to the
membrane, SPV-1 inhibits contractility by inactivating RHO-1See also Figure S3. Graphs show the intensity profile of lines drawn perpendic
5 mm.
(F) Quantification of constriction magnitude and valve-to-valve time in wild-t
SPV-1DF-BAR::GFP.
Data are represented as individual embryo transit events (gray dots) with m
duplicated from Figure 1D. Statistical comparisons were performed using onethrough its RhoGAP domain. Oocyte entry stretches the sper-
matheca cells, straightening out membrane curvature, and
thus leads to detachment of SPV-1, which, in turn, permits
the level of active RHO-1 to rise beyond a threshold needed
to induce contraction. An alternative explanation for SPV-1’s
transient localization, which we cannot rule out, is that soluble
signals from the oocyte induce a change in the spermatheca
apical membrane that leads to SPV-1 detachment.
Egg Shape Has Consequences for Embryonic
Development
We identified spv-1 as a gene that, when knocked down,
resulted in embryos with aberrant shape and 50% embryonic
lethality. Interestingly, we did not detect SPV-1::GFP expres-
sion in embryos. Crossing spv-1(ok1498) hermaphrodites
with wild-type males did not rescue the embryonic pheno-
types any more than crossing with spv-1(ok1498) males, sug-
gesting SPV-1 function is required in the mother and not in the
embryo. Consistent with that, driving SPV-1::GFP expression
in the spermatheca of spv-1(ok1498) using the sth-1 promoter
not only rescued spermatheca contractility and embryo shape
defects, but also completely restored the viability of the em-
bryos. Thus, we concluded that lethality in spv-1(RNAi) and
spv-1(ok1498) embryos is entirely due to their abnormal shape.
Premature arrest in embryonic development could be caused
by loss of cytoplasmic material as a result of embryos being
severed by overconstriction of the spermatheca, resulting in
small embryos. Another possible explanation for embryo ar-
rest could be the deviation from the normal geometric shape.
As evident in Figure S1A, abnormally long embryos developed
normally, whereas the rounder-than-normal embryos were
likely to arrest. The mechanistic relationship between embryo
shape and development in spv-1 mutants is a topic for future
investigation.
The F-BAR Domain of SPV-1, along with Its Metazoan
Orthologs, Forms a Novel Class of F-BAR Domains
Using DELTA-BLAST, we identified orthologs of SPV-1 in all
metazoan genomes we searched, as well as in the premeta-
zoan choanoflagellate M. brevicollis. The F-BAR domain we
identified in SPV-1 is well conserved in all its orthologs,
including the three human orthologs: ARHGAP29, GMIP, and
HMHA1. A phylogenetic analysis of SPV-1’s F-BAR domain
along with all known human F-BAR domains showed that the
F-BAR domain of SPV-1 orthologs form a distinct subfamily,
which may explain why they have not been recognized as
such to date, despite the fact that the crystal structure of
GMIP’s N terminus has been solved and displays a distinct
F-BAR fold. It will be interesting to test if the F-BAR domain
of SPV-1 orthologs also sense and selectively bind to curved
membranes in vivo, which might provide a mechanism to
regulate RhoGAP localization in mammalian cells.
Interplay between Calcium Signaling and RhoA Pathway
in Contractile Tubes
The myoepithelial spermathecal pouch in C. elegans is analo-
gous in terms of structure and function to contractile smoothular to the spermatheca cells. Scale bar, whole spermatheca, 20 mm; inset,
ype and spv-1(ok1498) worms expressing either full-length SPV-1::GFP or
ean 6 SEM. n R 23 for each worm strain analyzed. Wild-type values are
-way ANOVA-Tukey’s multiple comparisons test.
Figure 5. Transient Localization of SPV-1 Is
Essential for Embryo Transit
(A) Representative images of transgenic worm
spermatheca with chimeric SPV-1::GFP. The
F-BAR domain of SPV-1 was replaced with a
PH domain. The GFP panels indicate membrane
localization, whereas the DIC panel displays
multiple embryos in the spermatheca. Scale bar,
20 mm.
(B) Quantification of the maximum number of
embryos in the spermatheca during a 30 min
imaging period. Each dot represents an inde-
pendent experiment. n = 10 for each strain.
(C) Model illustrating the mechanism of sper-
matheca contractility regulation by transient
localization of SPV-1 at the membrane.
149muscle tubes in mammals, such as the respiratory tract, blood
vessels, and salivary ducts. Abnormal smooth muscle con-
tractions in these tissues result in severe pathological con-
ditions such as asthma and hypertension. Both RhoA and
calcium signaling have been implicated in regulation of
the constriction of airway smooth muscle cells and blood
vessels [40]. Although these two pathways have long been
established, they are usually identified as two independent
pathways, converging at the level of myosin light-chain phos-
phorylation [40, 41]. Recently, Kovacevic et al. reported that arise in calcium levels in the spermatheca,
triggered by oocyte entry and stretching
of the spermatheca cells, initiates the
constriction of the spermatheca and em-
bryo exit [21]. The oocyte entry-depen-
dent calcium release is regulated by
PLC-1 and its downstream partners,
raising the possibility that PLC-1 could
be under the regulation of RHO-1, as
suggested by studies in mammalian
cells [42]. It remains to be seen if SPV-
1, identified as a negative regulator of
RHO-1, could modulate calcium release
in addition to regulation of spermatheca
contractility via the RHO-1/LET-502
pathway.
Plasma Membrane as a Site of
Mechanical Regulation of RhoA
Tension-sensitive ion channels in pro-
karyotes provided the earliest evidence
for the plasma membrane as a site of
mechanotransduction. In bacterial cells,
the mechanosensitive channel of large
conductance (MscL) opens under high
osmotic pressure to allow the exit of
large solutes from cells to prevent cell
lysis [43]. More recently, the idea of
plasma membrane tension as a mechan-
ical cue to coordinate cell-shape change
in eukaryote cells has garnered evidence
[44–46]. Quantitative modeling of kerato-
cyte migration suggested that forces
imposed on the actin network by the
membrane play an essential role in
regulating actin assembly at the front
and disassembly at the rear of the cell,highlighting the importance of membrane tension in deter-
mining the shape of motile cells [47]. Using single-cell
spreading assays, Gauthier and colleagues have documented
a temporary spike in membrane tension after the initial cell-
spreading phase, which is followed by cycles of actomyosin
contractility and lamellipodia protrusion at the cell edge,
together with deposition of focal adhesions [48]. Coupling of
membrane curvature-sensitive domains to GAPs and GEFs
may provide a mechanism for regulating small GTPases
through a mechanical signal. In the case of ADP ribosylation
150factor (ARF)GAP1, presence of an ARFGAP1 lipid-packing
sensor (ALPS) domain, which binds favorably to positively
curvedmembranes, together with aGAPdomain have been re-
ported to hydrolyze the GTP of ARF in a curvature-dependent
manner during coat protein I (COPI) disassembly on Golgi
membranes [49]. However, molecular mechanisms that link
mechanical properties of the membrane to biochemical
pathways regulating actomyosin contractility have remained
elusive.
Based on our findings, we propose that SPV-1 functions as
a transducer of mechanical cues from the membrane to
regulate RHO-1-mediated contractility. It is very attractive to
speculate that coupling of a membrane curvature-sensitive
domain to RhoGAPs could function as a universal mechanism
to feedback between membrane curvature and initiation of
actomyosin contractility to drive cell-shape change during
cell migration or other morphogenic events.Experimental Procedures
C. elegans Strains and Worm Culture
C. elegans strains were grown on nematode growth medium (NGM) agar
seeded with OP50 Escherichia coli at 20C, unless otherwise specified.
Refer to Table S3 for a full list of strains used in this study. Transgenic strains
carrying msnEx arrays were generated by injecting DNA into the gonads of
adult hermaphrodites. The injection mix contained 5–10 ng/ml of target DNA
construct, 100 ng/ml of pBluescript plasmid, and 20 ng/ml of rol-6(su1006)
plasmid as a coinjection marker. At least two lines were generated and
imaged for each strain, except for the RhoGAP dead strain.
C. elegans Cross and Progeny Test
spv-1(ok1498) hermaphrodites were crossed with either spv-1(ok1498) or
wild-type males for 24 hr. Hermaphrodites were then singled out to lay
embryos. Embryos and the resulting hatched progenies were tabulated.
F1 progeny with a high incidence of males were considered cross-progeny,
and plates with no males were considered as non-cross-progeny and used
as controls.
RNAi
RNAi knockdown of gene expression was performed as previously
described [50]. Briefly, Knockdown of spv-1 was done by feeding L1 larva
with a Vidal library RNAi clone (OpenBioSystems) targeting spv-1 at 25C
for 48 hr. Worms were fed rho-1 Ahringer library RNAi clones (Source
BioScience) at 20C for 24 hr and 36 hr in the spv-1(ok1498) and wild-type
background respectively. Bacterial clones carrying an empty L4440 vector
and par-5 gene were used as negative and positive controls.
Molecular Biology
Refer to Supplemental Experimental Procedures for details of the various
constructs engineered.
RhoGAP Assay
The C terminus of SPV-1 containing the GAP domain was purified from
bacterial culture using a His tag. The activity of the GAP domain of SPV-1
on RhoA was evaluated using the RhoGAP assay (Cytoskeleton) according
to manufacturer’s protocol. p50RhoGAP catalytic domain was used as
a positive control. Release of inorganic phosphate (Pi) was measured at
A650 with a spectrophotometer (Tecan).
Bioinformatics
Protein domains of SPV-1 were identified by conducting a conserved
domain search [51]. The presence of coiled-coil region was determined
by Paircoil2 [30]. Phyre2 [34] and I-TASSER [37] were used to predict the
structure of full-length and F-BAR domain of SPV-1, respectively. SPV-1
orthologs were identified using DELTA-BLAST [35]. Multiple sequence
alignments were performed with T-coffee [52] and visualized using Jalview
[53]. Phylogenetic distances were calculated with PHYLIP-NEIGHBOR
(MPI Bioinformatics Toolkit) [54] and unrooted phylogenetic tree was drawn
with Dendroscope [55].Image Acquisition and Analysis
Young adult hermaphrodites with one-row embryos were immobilized for
imaging by mounting them on 10% agarose pads on glass slides. Embryo
mounts were prepared by excision of embryos from gravid hermaphrodites
andmounted onto 3% agarose pads. M9 buffer was used to prevent sample
desiccation. Normaski images and movies shown in Figures 1A, 1C, 1E, 2A,
and 5A (DIC panel), Figures S1C and S1E, Figure S2A, andMovies S1 and S2
were captured using a wide-field microscope. All other imaging was per-
formed with a spinning-disk confocal microscope. Refer to Supplemental
Experimental Procedures for a detailed description of the microscope
setup. Quantifications were performed using ImageJ (NIH) by manual selec-
tion of the regions of interest. Constriction magnitude was a measurement
of distal spermatheca width divided by proximal width. Valve-to-valve
time represented the elapsed time between distal valve closure and opening
of the sp-ut valve. Intensity changes of the Rho-biosensor wasmeasured by
quantifying the mean intensity of the middle focal plane of a spermatheca
across time relative to the intensity at the initial time point. Intensity at the
membrane and cytoplasm were quantified by manually tracing a line along
the cell edge or the cytoplasm. Mean intensity of the lines drawn at the
membrane divided by the values obtained for the cytoplasm provided
the membrane-to-cytoplasm ratio. Quantitative data sets were subjected
to statistical analysis (ordinary one-way ANOVA-Tukey’s multiple compari-
sons test for all figures, except S1B for which a two-tailed unpaired t test
was used) and graphs were drawn using the Prism 6 software (GraphPad).
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, three figures, three tables, and three movies and can be found with
this article online at http://dx.doi.org/10.1016/j.cub.2014.11.033.
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